Propionic Acid

Propionic Acid

SCHEMBL4155568

CCC(=O)O.CN(C)CC#Cc1ccc2[nH]c(=O)c3[nH]ccc3c2c1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
MET P08581 1/20 0.41
PIKFYVE Q9Y2I7 3/20 0.38
TBK1 Q9UHD2 1/20 0.38
STK16 O75716 1/20 0.36
CLK1 P49759 1/20 0.36
CLK2 P49760 1/20 0.36
DYRK1A Q13627 1/20 0.36
MYLK Q15746 1/20 0.36
MAP3K19 Q56UN5 1/20 0.36
MYLK4 Q86YV6 1/20 0.36
PIP4K2C Q8TBX8 1/20 0.36
HASPIN Q8TF76 1/20 0.36
AURKB Q96GD4 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
MAP4K5 Q9Y4K4 1/20 0.36
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4159519 0.87 MET (0.34) PIM1PIM2METPIKFYVEALDH1A1
Propionic Acid SCHEMBL4160296 0.85 GRM5 (0.44) PIM1PARP1GABRA1GABRG2GABRB3
Propionic Acid SCHEMBL4160262 0.83 GABRA1 (0.48) PIM1ALDH1A1GABRA1GABRG2GABRB3
Propionic Acid SCHEMBL4165408 0.82 GABRA1 (0.39) PIM1PIM2DYRK1AHASPINALDH1A1
Propionic Acid SCHEMBL4162291 0.82 PDE2A (0.39) PIKFYVEGABRA1GABRG2GABRB3GABRA3
Propionic Acid SCHEMBL4159601 0.80 MMP13 (0.42) ALDH1A1
Propionic Acid SCHEMBL4162445 0.79 AR (0.40) PIM1ALDH1A1CYP2C19PARP1TNKS
Propionic Acid SCHEMBL4159523 0.78 FFAR1 (0.43) GABRA1GABRG2GABRB3GABRA3GABRA2
Propionic Acid SCHEMBL4155220 0.78 FASN (0.41) PIM1PIM2GRIK1GRIK2GRIK3
SCHEMBL3245806 0.77 TBK1 (0.43) PIM1PIM2METPIKFYVETBK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 PIM1 279/4885PIM2 254/4885MET 1215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.